Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population

James A de Lemos, Christopher R. Defilippi

Research output: Contribution to journalArticle

9 Citations (Scopus)

Abstract

Cardiac troponins, when measured using highly sensitive assays, appear to be among the most powerful prognostic biomarkers yet identified for risk assessment in the general population. Very low troponin levels detectable with these highly sensitive assays are correlated with multiple clinical determinants of future heart failure risk and cardiovascular death. Corresponding imaging evidence of subclinical heart disease includes strong associations between cardiac troponins, left ventricular hypertrophy, and reduced left ventricular ejection fraction. This is in contrast to the poor correlation with coronary disease. Cardiac troponins provide complementary information to natriuretic peptides, as well as measures of renal function, and appear to outperform high-sensitivity C-reactive protein in predicting risk for a variety of cardiovascular disease endpoints. Additional research is now needed to define the role of highly sensitive troponin assays in screening of the general population and risk assessment.

Original languageEnglish (US)
Pages (from-to)705-709
Number of pages5
JournalCoronary Artery Disease
Volume24
Issue number8
DOIs
StatePublished - Dec 2013

Fingerprint

Troponin
Population
Natriuretic Peptides
Left Ventricular Hypertrophy
Stroke Volume
C-Reactive Protein
Coronary Disease
Heart Diseases
Cardiovascular Diseases
Heart Failure
Biomarkers
Kidney
Research

Keywords

  • biomarker
  • heart failure
  • outcomes
  • prognosis
  • risk stratification

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population. / de Lemos, James A; Defilippi, Christopher R.

In: Coronary Artery Disease, Vol. 24, No. 8, 12.2013, p. 705-709.

Research output: Contribution to journalArticle

@article{cc567caec6324a6a838dd4fa75842826,
title = "Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population",
abstract = "Cardiac troponins, when measured using highly sensitive assays, appear to be among the most powerful prognostic biomarkers yet identified for risk assessment in the general population. Very low troponin levels detectable with these highly sensitive assays are correlated with multiple clinical determinants of future heart failure risk and cardiovascular death. Corresponding imaging evidence of subclinical heart disease includes strong associations between cardiac troponins, left ventricular hypertrophy, and reduced left ventricular ejection fraction. This is in contrast to the poor correlation with coronary disease. Cardiac troponins provide complementary information to natriuretic peptides, as well as measures of renal function, and appear to outperform high-sensitivity C-reactive protein in predicting risk for a variety of cardiovascular disease endpoints. Additional research is now needed to define the role of highly sensitive troponin assays in screening of the general population and risk assessment.",
keywords = "biomarker, heart failure, outcomes, prognosis, risk stratification",
author = "{de Lemos}, {James A} and Defilippi, {Christopher R.}",
year = "2013",
month = "12",
doi = "10.1097/MCA.0000000000000048",
language = "English (US)",
volume = "24",
pages = "705--709",
journal = "Coronary Artery Disease",
issn = "0954-6928",
publisher = "Lippincott Williams and Wilkins",
number = "8",

}

TY - JOUR

T1 - Prevalence and significance of detectable troponins as measured by highly sensitive assays in the general population

AU - de Lemos, James A

AU - Defilippi, Christopher R.

PY - 2013/12

Y1 - 2013/12

N2 - Cardiac troponins, when measured using highly sensitive assays, appear to be among the most powerful prognostic biomarkers yet identified for risk assessment in the general population. Very low troponin levels detectable with these highly sensitive assays are correlated with multiple clinical determinants of future heart failure risk and cardiovascular death. Corresponding imaging evidence of subclinical heart disease includes strong associations between cardiac troponins, left ventricular hypertrophy, and reduced left ventricular ejection fraction. This is in contrast to the poor correlation with coronary disease. Cardiac troponins provide complementary information to natriuretic peptides, as well as measures of renal function, and appear to outperform high-sensitivity C-reactive protein in predicting risk for a variety of cardiovascular disease endpoints. Additional research is now needed to define the role of highly sensitive troponin assays in screening of the general population and risk assessment.

AB - Cardiac troponins, when measured using highly sensitive assays, appear to be among the most powerful prognostic biomarkers yet identified for risk assessment in the general population. Very low troponin levels detectable with these highly sensitive assays are correlated with multiple clinical determinants of future heart failure risk and cardiovascular death. Corresponding imaging evidence of subclinical heart disease includes strong associations between cardiac troponins, left ventricular hypertrophy, and reduced left ventricular ejection fraction. This is in contrast to the poor correlation with coronary disease. Cardiac troponins provide complementary information to natriuretic peptides, as well as measures of renal function, and appear to outperform high-sensitivity C-reactive protein in predicting risk for a variety of cardiovascular disease endpoints. Additional research is now needed to define the role of highly sensitive troponin assays in screening of the general population and risk assessment.

KW - biomarker

KW - heart failure

KW - outcomes

KW - prognosis

KW - risk stratification

UR - http://www.scopus.com/inward/record.url?scp=84888094390&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84888094390&partnerID=8YFLogxK

U2 - 10.1097/MCA.0000000000000048

DO - 10.1097/MCA.0000000000000048

M3 - Article

C2 - 24201087

AN - SCOPUS:84888094390

VL - 24

SP - 705

EP - 709

JO - Coronary Artery Disease

JF - Coronary Artery Disease

SN - 0954-6928

IS - 8

ER -